These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25516626)

  • 1. Good fats: lipidomics approach identify novel regulators of glucose homeostasis.
    Tuteja S
    Circ Cardiovasc Genet; 2014 Dec; 7(6):965-6. PubMed ID: 25516626
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism.
    Herman MA; Peroni OD; Villoria J; Schön MR; Abumrad NA; Blüher M; Klein S; Kahn BB
    Nature; 2012 Apr; 484(7394):333-8. PubMed ID: 22466288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle.
    Carvalho E; Kotani K; Peroni OD; Kahn BB
    Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E551-61. PubMed ID: 15928024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of ChREBP-Mediated Glucose Sensing into Whole Body Metabolism.
    Baraille F; Planchais J; Dentin R; Guilmeau S; Postic C
    Physiology (Bethesda); 2015 Nov; 30(6):428-37. PubMed ID: 26525342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver.
    Abel ED; Peroni O; Kim JK; Kim YB; Boss O; Hadro E; Minnemann T; Shulman GI; Kahn BB
    Nature; 2001 Feb; 409(6821):729-33. PubMed ID: 11217863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4.
    Katz EB; Stenbit AE; Hatton K; DePinho R; Charron MJ
    Nature; 1995 Sep; 377(6545):151-5. PubMed ID: 7675081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A new panorama for understanding the molecular connections between obesity and type 2 diabetes mellitus].
    Fernández-Mejía C
    Rev Invest Clin; 2001; 53(3):209-11. PubMed ID: 11496706
    [No Abstract]   [Full Text] [Related]  

  • 8. Glucose transporter proteins and insulin sensitivity in humans.
    Garvey WT
    Braz J Med Biol Res; 1994 Apr; 27(4):933-9. PubMed ID: 8087095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance in diabetes mellitus. Defective insulin-regulatable glucose transport plays an important role.
    Livingstone C; Gould GW
    Scott Med J; 1995 Apr; 40(2):37-9. PubMed ID: 7618066
    [No Abstract]   [Full Text] [Related]  

  • 10. [An unexpected partnership in fat cells: hormone-sensitive lipase and the transcription factor ChREBP jointly control insulin-sensitivity].
    Morigny P; Langin D
    Med Sci (Paris); 2019; 35(6-7):501-503. PubMed ID: 31274075
    [No Abstract]   [Full Text] [Related]  

  • 11. Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus.
    Shepherd PR; Kahn BB
    N Engl J Med; 1999 Jul; 341(4):248-57. PubMed ID: 10413738
    [No Abstract]   [Full Text] [Related]  

  • 12. Calorie restriction improves whole-body glucose disposal and insulin resistance in association with the increased adipocyte-specific GLUT4 expression in Otsuka Long-Evans Tokushima fatty rats.
    Park SY; Choi GH; Choi HI; Ryu J; Jung CY; Lee W
    Arch Biochem Biophys; 2005 Apr; 436(2):276-84. PubMed ID: 15797240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Br]eaking FAt.
    Ussar S; Tschöp MH
    Cell; 2014 Oct; 159(2):238-40. PubMed ID: 25303521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization.
    Kotani K; Peroni OD; Minokoshi Y; Boss O; Kahn BB
    J Clin Invest; 2004 Dec; 114(11):1666-75. PubMed ID: 15578099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes: The good in fat.
    Muoio DM; Newgard CB
    Nature; 2014 Dec; 516(7529):49-50. PubMed ID: 25409152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose-Sensing Transcription Factor MondoA/ChREBP as Targets for Type 2 Diabetes: Opportunities and Challenges.
    Song Z; Yang H; Zhou L; Yang F
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31623194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism: A is for adipokine.
    Muoio DM; Newgard CB
    Nature; 2005 Jul; 436(7049):337-8. PubMed ID: 16034406
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic fuel selection: the importance of being flexible.
    Bickel PE
    J Clin Invest; 2004 Dec; 114(11):1547-9. PubMed ID: 15578087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes. Dialogue between muscle and fat.
    Birnbaum MJ
    Nature; 2001 Feb; 409(6821):672-3. PubMed ID: 11217842
    [No Abstract]   [Full Text] [Related]  

  • 20. MUNC-ing around with insulin action.
    James DE
    J Clin Invest; 2005 Feb; 115(2):219-21. PubMed ID: 15690075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.